Not finding it? Sign in to also search OpenAlex live.
-
Patients with clinically diagnosed hand OA not fulfilling the ACR classification criteria are in an earlier disease phase and more often have thumb base OA2023 Osteoarthritis and Cartilage Open article Medicine Osteoarthritis Treatment and Mechanisms Open access
Sjoerd van Beest, Lotte A. van de Stadt, Frits Richard Rosendaal, M. Kloppenburg
5citations -
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
Cathalijne Post, Stephanie M. de Boer, Melanie E. B. Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, +23 more
44citations -
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial2025 Obstetrical & Gynecological Survey article Medicine Endometrial and Cervical Cancer Treatments Open access
Cathalijne Post, Stephanie M. de Boer, Melanie E. B. Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, +23 more
1citations -
Lesions hyper- to isointense to surrounding liver in the hepatobiliary phase of gadoxetic acid-enhanced MRI2024 European Radiology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Alicia Furumaya, François E.J.A. Willemssen, Razvan L. Miclea, Martijn P. D. Haring, Robbert J. de Haas, Shirin Feshtali, +9 more
4citations -
Stage Migration on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Comparison to Conventional Imaging in Patients with High-risk Prostate Cancer Referred for Radiation Therapy: Results from the Phase 2/3 THUNDER Trial
Fleur Kleiburg, Piet R. Dirix, Valérie Fonteyne, Samuel Bral, Bart De Troyer, Brieuc R. Sautois, +13 more
10citations -
CCTG EN10: A phase II study of tailored adjuvant therapy in POLE-mutated and p53-wildtype/NSMP early-stage endometrial cancer (EC)—RAINBO BLUE and TAPER.2023 Journal of Clinical Oncology conference-abstract Medicine Endometrial and Cervical Cancer Treatments Open access
Jessica Nell McAlpine, Kathy Chai-Zung Han, Mary A. Kinloch, Maroie Barkati, Sarah Elizabeth Ferguson, Anthony Fyles, +13 more
8citations -
The RAINBO MMRd-GREEN trial (GCIG/DGOG/ENGOT-EN142): A phase III trial on the addition of adjuvant durvalumab to radiotherapy in patients with high-risk MMRd endometrial cancer.2023 Journal of Clinical Oncology conference-abstract Medicine Endometrial and Cervical Cancer Treatments
Merve Kaya, Nanda Horeweg, Alexandra F. Leary, Stephen A. Welch, Stefan Kommoss, Nicola Weidner, +13 more
5citations -
2023 EULAR classification criteria for hand osteoarthritis2024 Annals of the Rheumatic Diseases article Medicine Osteoarthritis Treatment and Mechanisms Open access
Ida Kristin Haugen, David T. Felson, Abhishek Abhishek, Françis Berenbaum, Sita Bierma-Zeinstra, Krysia Dziedzic, +25 more
30citations -
Multiphase CT-based prediction of Child-Pugh classification: a machine learning approach2020 European Radiology Experimental article Medicine Radiomics and Machine Learning in Medical Imaging Open access
Johannes Thüring, Oliver Rippel, Christoph Haarburger, Dorit Merhof, Philipp Schad, Philipp Bruners, +2 more
18citations -
E068 Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2
Xenofon Baraliakos, Sofía Ramiro, Marina Magrey, Martín Rudwaleit, Nigil Haroon, Carmen Fleurinck, +5 more
0citations -
How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 20242025 Annals of Hematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Martin Grießhammer, Haifa Kathrin Al‐Ali, Jan‐Niklas Eckardt, Michael Fiegl, Joachim Rudolf Göthert, Kathleen Jentsch‐Ullrich, +5 more
11citations -
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis2023 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Jürgen Braun, Ricardo Blanco, Helena Marzo‐Ortega, Lianne S. Gensler, Filip E Van den Bosch, Stephen Hall, +7 more
22citations -
POS0920 BIMEKIZUMAB DEMONSTRATES COMPARABLE ONE-YEAR EFFICACY IN MALE AND FEMALE PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Martín Rudwaleit, S. Ramiro, Denis Poddubnyy, M. Magrey, Irene E. van der Horst-Bruinsma, Atul A. Deodhar, +4 more
0citations -
MON-LB53 Prior Injectable Somatostatin Receptor Ligand Dose Does Not Predict Oral Octreotide Response In The Treatment Of Acromegaly: Results From The Phase 3 OPTIMAL Study2020 Journal of the Endocrine Society article Medicine Pituitary Gland Disorders and Treatments Open access
Lisa B. Nachtigall, Susan Leanne Samson, Maria Fleseriu, Marek Bolanowski, William Henry Ludlam, Gary Patou, +7 more
0citations -
Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study2025 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Filip E Van den Bosch, Atul A. Deodhar, Denis Poddubnyy, Walter P. Maksymowych, Désirée M F M van der Heijde, Tae-Hwan Kim, +8 more
10citations